Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Long-term Safety of Apremilast Treatment in Psoriasis and Psoriatic Arthritis Patients: Pooled Analysis for 156 Weeks and Beyond in the ESTEEM 1 and 2 and PALACE 1‒3 Phase 3 Trials. American Academy of Dermatology (AAD) Annual Meeting, Orlando, Mar 2017.
American Academy of Dermatology (AAD) Annual Meeting (2017)
  • J Crowley
  • J Wollenhaupt
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Link
Disciplines
Publication Date
March, 2017
Citation Information
J Crowley, J Wollenhaupt, Philip Mease and et.al.. "Long-term Safety of Apremilast Treatment in Psoriasis and Psoriatic Arthritis Patients: Pooled Analysis for 156 Weeks and Beyond in the ESTEEM 1 and 2 and PALACE 1‒3 Phase 3 Trials. American Academy of Dermatology (AAD) Annual Meeting, Orlando, Mar 2017." American Academy of Dermatology (AAD) Annual Meeting (2017)
Available at: http://works.bepress.com/philip-mease/280/